They are.

They're getting into finance and drug discovery now, probably because the profit numbers for selling tokens look pretty dismal over the long term, and investors are looking for a way to service all that debt.

And guess what: they've already distilled the alpha out of businesses who went all-in on AI, so they already have some business models ready to go. Your business models, if you are an executive at such a company.